Cooperation network
In collaboration with international key opinion leaders, SphingoTec develops fundamental solutions for fighting mortality in critical care settings. Following intensive collaborations with an international network of partners, SphingoTec has developed innovative biomarkers based on the highest standard of evidence.
>100,000
Patients
>100
Clinical Studies
>100
Scientific Publications
>250
Granted Patents
Discover more on the scientific evidence
SphingoTec's biomarker discovery is based on the highest standard of evidence, with over 100 publications, over 100 clinical studies, and more than 100.000 patients enrolled. To discover more on our scientific research, visit our publications page.